GM-CSF_NN
and_CC
IL-2_NN
share_VBP
common_JJ
control_NN
mechanisms_NNS
in_IN
response_NN
to_TO
costimulatory_JJ
signals_NNS
in_IN
T_NN
cells_NNS
._.

Antigen_NN
complexed_VBN
with_IN
major_JJ
histocompatibility_NN
complex_NN
class_NN
I_CD
or_CC
II_CD
molecules_NNS
on_IN
the_DT
surface_NN
of_IN
antigen_NN
presenting_NN
cells_NNS
interacts_VBZ
with_IN
the_DT
T_NN
cell_NN
receptor_NN
-LRB-_-LRB-
TCR_NN
-RRB-_-RRB-
on_IN
the_DT
surface_NN
of_IN
T_NN
cells_NNS
and_CC
initiates_VBZ
an_DT
activation_NN
cascade_NN
._.

So_RB
called_VBN
costimulatory_JJ
signals_NNS
,_,
mediated_VBN
by_IN
other_JJ
cell_NN
surface_NN
interactions_NNS
or_CC
soluble_JJ
cytokines_NNS
produced_VBN
by_IN
antigen_NN
presenting_NN
cells_NNS
,_,
are_VBP
also_RB
required_VBN
for_IN
complete_JJ
T_NN
cell_NN
activation_NN
._.

High_JJ
levels_NNS
of_IN
cytokine_NN
gene_NN
expression_NN
in_IN
T_NN
cells_NNS
also_RB
required_VBD
both_CC
TCR_NN
and_CC
costimulatory_JJ
signals_NNS
._.

The_DT
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
requires_VBZ
sequences_NNS
in_IN
the_DT
promoter_NN
as_RB
well_RB
as_IN
a_DT
powerful_JJ
enhancer_NN
located_JJ
3kb_RB
upstream_RB
to_TO
respond_VB
to_TO
TCR-like_JJ
signals_NNS
._.

These_DT
promoter_NN
and_CC
enhancer_NN
regions_NNS
are_VBP
mainly_RB
activated_VBN
by_IN
the_DT
transcription_NN
factor_NN
nuclear_JJ
factor_NN
of_IN
activated_VBN
T_NN
cells_NNS
-LRB-_-LRB-
NFAT_NN
-RRB-_-RRB-
._.

The_DT
activation_NN
of_IN
NFAT_NN
by_IN
TCR_NN
signals_NNS
has_VBZ
been_VBN
well_RB
described_VBN
for_IN
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
and_CC
IL-4_NN
gene_NN
transcription_NN
in_IN
T_NN
cells_NNS
._.

Costimulatory_JJ
signals_NNS
,_,
such_JJ
as_IN
activation_NN
of_IN
the_DT
CD28_NN
cell_NN
surface_NN
molecule_NN
on_IN
T_NN
cells_NNS
,_,
lead_VBP
to_TO
activation_NN
through_IN
a_DT
distinct_JJ
region_NN
of_IN
the_DT
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
GM-CSF_NN
-RRB-_-RRB-
promoter_NN
._.

This_DT
region_NN
is_VBZ
termed_VBN
the_DT
CK-1_NN
or_CC
CD28RE_NN
and_CC
appears_VBZ
to_TO
bind_VB
specific_JJ
members_NNS
of_IN
the_DT
NF-kappa_NN
B_NN
family_NN
of_IN
transcription_NN
factors_NNS
._.

Human_JJ
T_NN
leukemia_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HTLV-1_NN
-RRB-_-RRB-
infects_VBZ
T_NN
cells_NNS
and_CC
can_MD
lead_VB
to_TO
increase_VB
GM-CSF_NN
expression_NN
._.

We_PRP
have_VBP
found_VBN
that_IN
the_DT
HTLV-1_NN
transactivator_NN
protein_NN
,_,
tax_NN
,_,
acts_VBZ
as_IN
a_DT
costimulatory_JJ
signal_NN
for_IN
GM-CSF_NN
and_CC
IL-2_NN
gene_NN
transcription_NN
,_,
in_IN
that_WDT
it_PRP
can_MD
cooperate_VB
with_IN
TCR_NN
signals_NNS
to_TO
mediate_VB
high_JJ
level_NN
gene_NN
expression_NN
._.

Tax_NN
activates_VBZ
the_DT
GM-CSF_NN
promoter_NN
through_IN
the_DT
CK-1_NN
\/_:
CD28RE_NN
region_NN
and_CC
also_RB
activates_VBZ
nuclear_JJ
factor-kappa_NN
B_NN
binding_NN
to_TO
this_DT
region_NN
._.

However_RB
,_,
other_JJ
transcription_NN
factors_NNS
or_CC
coactivators_NNS
of_IN
NF-kappa_NN
B_NN
are_VBP
required_VBN
for_IN
tax_NN
activation_NN
but_CC
these_DT
remain_VBP
to_TO
be_VB
identified_VBN
._.

The_DT
CK-1_NN
\/_:
CD28RE_NN
of_IN
GM-CSF_NN
shows_VBZ
a_DT
high_JJ
degree_NN
of_IN
similarity_NN
to_TO
the_DT
IL-2_NN
CD28RE_NN
and_CC
the_DT
IL-3_NN
gene_NN
also_RB
contains_VBZ
a_DT
related_JJ
region_NN
._.

This_DT
observation_NN
,_,
together_RB
with_IN
the_DT
fact_NN
that_IN
both_CC
GM-CSF_NN
and_CC
IL-2_NN
respond_VBP
to_TO
TCR_NN
signals_NNS
via_IN
NFAT_NN
,_,
implies_VBZ
a_DT
high_JJ
degree_NN
of_IN
conservation_NN
in_IN
the_DT
regulation_NN
of_IN
cytokine_NN
gene_NN
expression_NN
in_IN
T_NN
cells_NNS
._.

